KineMed Inc. (www.kinemed.com)
today announced an agreement with MedImmune, the global biologics
research and development arm of AstraZeneca, to study how a monoclonal
... read more
KineMed (www.kinemed.com)
announced today that Dr. Patrizia Fanara, Vice President, Neuroscience
at KineMed, Inc., will present recent progress in the development of
... read more
KineMed, Inc., Isis Pharmaceuticals Inc. (NASDAQ: ISIS), and CHDI
Foundation, Inc., announced today that they are collaborating to utilize
KineMed’s translational biomarker platform with Isis’ antisense
... read more
KineMed, Inc. (www.kinemed.com)
announced today that David Fineman, President and CEO of KineMed, Inc.
will present at the 15th Annual BIO CEO & Investor Conference taking
... read more
KineMed, Inc. (www.kinemed.com)
announced today that David Fineman, KineMed’s CEO will present at the
2013 Biotech Showcase Conference on Monday, January 7th at 2:00 p.m. on
... read more